West Lodge Holdings has been acquired by Prestige Care Group
October 2025 — West Lodge Care Home, part of West Lodge Holdings Limited, has been acquired by UK-based care home provider Prestige Care Group Limited, marking an important milestone in the continued growth and consolidation of high‑quality elderly care provision across the region.
West Lodge Care Home is a family-owned residential care home near Crook, County Durham, that offers long-term care for people aged 65 and older. Established in 1996, it provides residential care for up to 60 residents. As part of the transaction, the existing management team will remain with the business to support a smooth operational and cultural handover to the new owners.
Prestige Care Group is a Northeast UK care home provider with over 25 years’ experience delivering residential, nursing and dementia care. The group operates multiple purpose-built care centers offering person-centred support, aiming to treat each resident as an individual and provide both high-quality care and a home-from-home atmosphere. It comprises eight care homes and employs more than 350 staff, offering residential care to older people across the region.
Our role in the transaction
Oaklins S&W, based in the UK, acted as the sell side advisors, fielding due diligence inquiries and managing the project through to completion.
Anton Price
West Lodge Care Home
Contacter l'équipe de la transaction
Transactions connexes
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
En apprendre plusLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
En apprendre plusRöntgeninstitut Aarau has been acquired by Evidia
The owners of Röntgeninstitut Aarau have sold the business to Evidia Group as part of their succession planning. The former owners will remain involved in the institute and support its future development alongside Evidia.
En apprendre plus